List of Excipients in API buprenorphine hydrochloride and naloxone hydrochloride dihydrate
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Detailed excipient profiles for buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Excipient focus: ACESULFAME POTASSIUM
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing ACESULFAME POTASSIUM
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing ACESULFAME POTASSIUM
Excipient focus: ALUMINUM OXIDE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing ALUMINUM OXIDE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS CITRIC ACID
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing ANHYDROUS CITRIC ACID
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing ANHYDROUS LACTOSE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CROSPOVIDONE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing CROSPOVIDONE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing CROSPOVIDONE
Excipient focus: FD&C YELLOW NO. 6
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing FD&C YELLOW NO. 6
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing FD&C YELLOW NO. 6
Excipient focus: LACTOSE MONOHYDRATE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing LACTOSE MONOHYDRATE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing MAGNESIUM STEARATE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing MANNITOL
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing POVIDONE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing SODIUM CITRATE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing SODIUM CITRATE
Excipient focus: STARCH, CORN
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing STARCH, CORN
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing SUCRALOSE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing SUCRALOSE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants containing TRISODIUM CITRATE DIHYDRATE
buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug variants not containing TRISODIUM CITRATE DIHYDRATE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
